Top Markets
#1 Zora Zora +30.17%
#2 AI XOVIA AI XOVIA +27.52%
#3 Full Moon Full Moon +18.73%
#4 0G 0G +18.64%
#5 Notcoin Notcoin +17.28%
#6 Axelar Axelar +12.61%
#7 Wrapped NXM Wrapped NXM +12.33%
#8 rsERG rsERG +12.24%
#9 Helium Helium +11.58%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.55%
Coin of the day
Zora Zora
설정
언어
한국어
통화
USD
테마
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
주식 순위 #12599
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
주가
$9.09
마지막 동기화: 2023-06-23
시가총액
$567.77M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 CTI BioPharma Corp. (CTIC)

카테고리

Healthcare
CTI BioPharma Corp. (CTIC)의 EPS
2026 기준 EPS TTM: 0
CTI BioPharma Corp.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
CTI BioPharma Corp.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH